Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Earns CEO Cancer Gold Standard™ Re-Accreditation
PHILADELPHIA (June 7, 2019) – Fox Chase Cancer Center has earned CEO Cancer Gold Standard re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the latest comprehensive requirements of the Gold Standard.
“Fox Chase is home to many world class physicians, scientists, and staff, and as an institution we are as dedicated to reducing their risk of cancer as we are to caring for our patients. It’s an honor to be recognized for this effort,” said Richard I. Fisher, MD, president and CEO of Fox Chase Cancer Center.
Employers from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they take steps to address cancer and other chronic diseases. Over 200 private, nonprofit and government employers in a wide range of industries have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
The CEO Roundtable on Cancer, a nonprofit organization of CEOs founded by President George H.W. Bush, created the Gold Standard to recognize employers for taking exceptional health and wellness measures on behalf of their employees.
To earn Gold Standard accreditation, an employer must take concrete actions to reduce the risk and burden of cancer: prohibit tobacco use and support tobacco cessation efforts; promote physical activity, healthy nutrition and weight management; provide health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promote employee awareness of these initiatives; and support the needs of cancer survivors in the workplace.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427